Hydroxytyrosol affects antioxidant Nrf2 expression in the kidneys of diabetic rats
Open Access
- 30 April 2024
- journal article
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (2) , 87-94
Abstract
Aim: Diabetic nephropathy is the result of oxidative stress caused by chronic hyperglycemia. Nuclear factor erythroid 2-related factor 2 (Nrf2) is an important transcription factor that responds to oxidative stress. Nrf2 relieves oxidative stress, inflammation, and fibrosis associated with diabetes in the kidneys. In this study, we investigated the effects of hydroxytyrosol, which is a polyphenolic compound with proven antioxidant activity, on Nrf2 expression in diabetic kidneys. Methods: Forty male Wistar rats were used in our study and the rats were divided into four groups as control (sterile water only), hydroxytyrosol (HT) (10mg/kg hydroxytyrosol administered intraperitoneally (ip) for 30 days), streptozotocin (STZ) (diabetes was induced by administering a single dose of 55 mg/kg streptozotocin ip), and streptozotocin + hydroxytyrosol (STZ+HT) (single dose of 55 mg/kg streptozotocin and 10 mg/kg hydroxytyrosol administered ip for 30 days). At the end of the study, Nrf2 expression in kidney tissue was evaluated by immunohistochemistry and Western blot. Results: Immunohistochemistry and Western blot findings of Nrf2 were similar. It was found that while Nrf2 expression increased significantly in the HT group compared to the control group, whereas it decreased significantly in the STZ group (p<0.001). In the STZ+HT group, Nrf2 expression was found to be significantly increased compared to the STZ group (p<0.001). Conclusions: It was found that hydroxytyrosol with known antioxidant activity increased Nrf2 expression in diabetic rats. These results suggest that hydroxytyrosol may mitigate diabetic nephropathy by Nrf2-induced reduction in oxidative stress, inflammation, and fibrosis.Keywords
This publication has 34 references indexed in Scilit:
- The effects of hydroxytyrosol on Prdx6 and insulin expression in diabetic rat pancreasesHistochemistry and Cell Biology, 2023
- Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospectiveBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- tBHQ attenuates podocyte injury in diabetic nephropathy by inhibiting NADPH oxidase-derived ROS generation via the Nrf2/HO-1 signalling pathwayHeliyon, 2022
- Influence of Tangeretin on the Exponential Regression of Inflammation and Oxidative Stress in Streptozotocin-Induced Diabetic NephropathyApplied Biochemistry and Biotechnology, 2022
- P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2019
- Hydroxytyrosol butyrate inhibits 6-OHDA-induced apoptosis through activation of the Nrf2/HO-1 axis in SH-SY5Y cellsEuropean Journal of Pharmacology, 2018
- Endogenous non-enzymatic antioxidants in the human bodyAdvances in Medical Sciences, 2018
- Diabetic nephropathy: Is there a role for oxidative stress?Free Radical Biology and Medicine, 2018
- Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathwaysInternational Immunopharmacology, 2018
- Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic AdenocarcinomaPathology and Oncology Research, 2015